Overcoming adaptive therapy resistance in AML by targeting immune response pathwaysKatelyn Melgar, Daniel T. Starczynowski, Kathleen Hueneman et al.|Science Translational Medicine|2019Cited by 88
RUNX represses <i>Pmp22</i> to drive neurofibromagenesisAshley Hall, Jianqiang Wu, Kwangmin Choi et al.|Science Advances|2019Cited by 13